Bio Protocol price forecast after Coinbase added BIO and EUL to listing roadmap

The price of Bio Protocol (BIO) has surged recently following Coinbase’s decision to add the token, along with Euler (EUL), to its asset listing roadmap. This move by the top-tier US exchange triggered strong market interest, pushing BIO into bullish territory with sharp upward momentum and renewed investor attention. Coinbase announced on July 29 via X (formerly Twitter), indicating that both BIO and EUL are now under consideration for future listing on its platform. While a listing is not guaranteed, such roadmap additions often spark increased buying pressure — a phenomenon widely known as the “Coinbase effect.” Bio Protocol price reacted swiftly to the roadmap addition Immediately after Coinbase’s announcement, BIO jumped from $0.0612 to $0.07916, representing a nearly 30% surge. Although it later pared some gains, the token remained up by about 17% at the time of reporting. EUL also experienced an initial 22% price spike but soon retraced, settling with a more modest 3.5% gain. Notably, the surge in BIO’s price is consistent with past reactions to Coinbase roadmap news. Investors typically view such developments as a signal of legitimacy, especially when they involve tokens that are already trading on other reputable exchanges. In BIO’s case, the token is already listed on Binance, OKX, Kraken, KuCoin, and others, which has helped provide liquidity and limit downside volatility. The bullish trend is supported by a strong technical setup From a technical standpoint, BIO has shown signs of a bullish reversal pattern. A rounded bottom formation emerged recently, often interpreted as a precursor to trend shifts. Bio Protocol price chart | Source: TradingView After a prolonged downturn, the token has begun climbing steadily, breaking above critical resistance levels and forming higher lows. Currently, the Bio Protocol price is consolidating around the $0.0690 zone following an aggressive liquidity sweep above $0.0750. This move likely triggered stop orders and absorbed selling pressure before the price dipped slightly. However, buyers appear to be holding the $0.0690 support level, which keeps the bullish structure intact on the 1-hour chart. If the uptrend resumes, the next resistance targets sit at $0.0940, $0.1258, and $0.1660. These levels are widely watched by traders, and a break above each could invite further momentum. Based on current positioning, analysts estimate a potential 136% upside from current levels if the bullish structure continues to hold. Risk of downside if support fails Despite the optimistic outlook, the short-term technical picture comes with caution. If the $0.0690 support breaks down, the Bio Protocol price could decline toward the next demand zone around $0.0630. Such a move would still maintain the overall bullish trend, as long as the ascending trendline on the hourly chart remains intact. Market sentiment will also play a role in determining whether buyers re-enter at these lower levels. Given the volatility of small-cap altcoins, traders should closely monitor Bio Protocol’s price action and be aware of fakeouts like the one seen near $0.0750. A second rejection at that level without new volume inflows could invite short-term selling pressure. The post Bio Protocol price forecast after Coinbase added BIO and EUL to listing roadmap appeared first on Invezz

Source: Invezz